Trials / Conditions / AML (Acute Myeloid Leukemia)

AML (Acute Myeloid Leukemia)

20 registered clinical trials studyying AML (Acute Myeloid Leukemia) — 19 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	FLT3-ITD Targeted Therapy in Fit AML Patients NCT07425808	European Organisation for Research and Treatment of Cancer - EORTC	Phase 2 / Phase 3
Recruiting	VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial NCT07514832	Beijing 302 Hospital	Phase 2
Not Yet Recruiting	CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS NCT07347418	University of Colorado, Denver	Phase 1
Recruiting	Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies NCT07486713	Rigel Pharmaceuticals	Phase 4
Recruiting	WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Expl NCT07511829	University of Oxford	—
Not Yet Recruiting	Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia NCT07370064	Xuzhou Medical University	Phase 1 / Phase 2
Not Yet Recruiting	Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatm NCT07342244	Donghua Zhang	N/A
Not Yet Recruiting	Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML NCT07338357	First Affiliated Hospital of Guangxi Medical University	EARLY_Phase 1
Not Yet Recruiting	Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantat NCT07214064	University Hospital Tuebingen	Phase 2
Not Yet Recruiting	Clinical Study of Selinexor-Based Chemotherapy With Minimal or No Cytotoxic Agents in Treatment-Naïve AML Pati NCT07236931	Donghua Zhang	N/A
Not Yet Recruiting	Prognostic Impacts of Lipid Profile and BMI in Adult AML NCT07143877	Assiut University	—
Not Yet Recruiting	CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute M NCT07201727	Institute of Hematology & Blood Diseases Hospital, China	EARLY_Phase 1
Enrolling By Invitation	A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Ve NCT07014462	University of Vermont	Phase 1
Not Yet Recruiting	Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoin NCT07025824	Technische Universität Dresden	Phase 2
Recruiting	Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML NCT07304232	Institute of Hematology & Blood Diseases Hospital, China	Phase 2
Recruiting	A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias NCT06994676	Crossbow Therapeutics, Inc.	Phase 1
Recruiting	Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX NCT06782971	Clinical Hub for Interventional Research (CHOIR)	—
Recruiting	Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible fo NCT06696183	Technische Universität Dresden	Phase 2
Recruiting	Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN NCT06690827	Chongqing Precision Biotech Co., Ltd	Phase 1
Terminated	Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders NCT03198234	Roncarolo, Maria Grazia, MD	Phase 1